more interest in abuse-deterrent opioid formulations

May 2014

You'll see more interest in abuse-deterrent opioid formulations.

This is stemming from the controversy surrounding the new long-acting hydrocodone med, Zohydro ER. It's NOT an abuse-deterrent form...despite concerns about its abuse potential.

Abuse-deterrent formulations aren't required by FDA yet...but are being promoted in an effort to reduce prescription opioid abuse.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Respiratory & Allergy when and how to use spacers with metered-dose inhalers (MDIs)
Cough & Cold confusion over the new Mucinex Allergy product
Antifungals a new Rx cream called Luzu (LOO-zoo, luliconazole) to treat fungal skin infections (ringworm, jock itch, etc)
Elderly Patients avoiding high-risk meds in the elderly
Cardiology new approaches to improve medication use in patients who have had a recent heart attack or "MI" (myocardial infarction)
Alzheimer's Disease handling Namenda (memantine) Rxs
Anticoagulants handling Rxs for oral blood thinners (warfarin, Pradaxa, Xarelto, etc)
PCOS changes in treatment of polycystic ovary syndrome (PCOS)
Supplements Patients are asking if multivitamins are beneficial
Diabetes meds can increase the risk of diabetes
Opioids more interest in abuse-deterrent opioid formulations
Testosterone The new IM injection, Aveed (uh-VEED, testosterone undecanoate), is adding fuel to the debate over treating "low T" in older men

more interest in abuse-deterrent opioid formulations

Practical advice for a better career, with unlimited access to CE

Table of Contents